Brief: Peptonic Signs License Agreement With Prima Lab Regarding Menopause Test
July 11 (Reuters) - Peptonic Medical AB PMED.TE :
* PEPTONIC SIGNS LICENSE AGREEMENT WITH PRIMA LAB REGARDING
MENOPAUSE TEST
* AGREEMENT MEANS THAT PEPTONIC GETS RIGHT TO SELL PRIMA
LAB'S
SELF-TEST FOR FSH HORMONE UNDER ITS OWN BRAND VAGIVITAL® IN
SWEDEN
* PLANNED LAUNCH IN EARLY 2024
Source text for Eikon: ID:nWkr5X3gkB
Further company coverage: PMED.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Peptonic Medical AB
See all newsSweden's Peptonic Medical Q2 sales drop, gross margin narrows
Brief: Peptonic Medical Q2 Sales SEK 2.36 Million
Sweden's Peptonic Medical Q1 operating loss narrows on restructuring
Brief: Peptonic Medical Q1 Sales SEK 3.138 Million
Sweden's Peptonic Medical Q4 sales fall, margin improves on restructuring efforts